RecruitingNot ApplicableNCT07283328

Methionine Intake Microbiota

Shaping Gut Microbiota Through a Dietary Intervention to Regulate Inflammatory Processes

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

40 participants

Start Date

Aug 20, 2024

Study Type

INTERVENTIONAL

Conditions

Healthy

Summary

Pro-inflammatory immune cells play a pivotal role in multiple sclerosis, and the gut microbiota is increasingly recognized as a key factor shaping the immune system. This study aims to determine the impact of a dietary intervention (methionine-restricted diet-MR) on gut microbiota and inflammation in humans. A randomized interventional pilot study with cross-over intervention is conducted in 40 healthy participants. For all participants, the first two weeks (week 1+week 2) consist of baseline assessment on their usual diet, and week 3+week 4 consist of MR diet only. For group A, the week 5+week 6 are MR+1,500 mg daily supplementation of methionine and for group B are MR+placebo, with a cross-over for week 7+week 8. Usual diet is resumed for all participants during week 9+week 10. Gut microbiota, blood levels of methionine and its metabolites, as well as immune and inflammatory markers will be evaluated every 2 weeks. It is hypothesized that MR could be used in humans to prevent and alleviate the course of multiple sclerosis by shaping the gut microbiota towards an anti-inflammatory profile, and that the gut microbiota is a biomarker associated with successful dietary interventions targeting inflammation in multiple sclerosis.

Eligibility

Min Age: 20 YearsMax Age: 50 Years

Inclusion Criteria4

Healthy adults
-50 years old
On omnivorous/western diet
Understanding French or English

Exclusion Criteria10

B12 deficiency
Glomerular filtration rate <75 ml/h
Liver dysfunction
Pregnant or lactating
Active inflammatory or infectious disease
Insulino-dependent diabetes
Active cancer
Eating disorder
BMI < 18.5 kg/m2
Severe food allergies or intestinal problems or active substance dependence that would prevent adherence to the experimental diet

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMethionine-restricted diet

Methionine-restricted diet (plant-based diet) is a feasible and palatable way to achieve 50% reduction in methionine intake. Reduction to around 800 mg/day methionine will be achieved using participants' selection from low-methionine plant-based and ready to eat meals for 100% of their meals, for 6 weeks. Participants will be provided with education and a list of low methionine content food (green) and high methionine (red) for eating out, snacks and homemade meals.